Comment on "Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients"

被引：3
|
作者：
Ballmann, Manfred [1 ]
Prinz, Nicole [2 ]
Glass, Aenne [3 ]
Holl, Reinhard [2 ]
机构：
[1] Univ Med Pediat Clin, Ernst Heydemann Str 8, D-18057 Rostock, Germany
[2] Univ Ulm, Inst Epidemiol & Med Biometry, Albert Einstein Allee 41, D-89081 Ulm, Germany
[3] Univ Med Rostock, Inst Biostat & Informat Med & Age Res IBIMA, Ernst Heydemann Str 8, D-18057 Rostock, Germany
来源：
JOURNAL OF CYSTIC FIBROSIS | 2020年 / 19卷 / 05期
关键词：
D O I：
10.1016/j.jcf.2020.04.009
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：839 / 839
页数：1
相关论文
共 50 条
  • [31] Effect of Lumacaftor/Ivacaftor on glucose metabolism and insulin secretion in Phe508del homozygous cystic fibrosis patients
    Thomassen, Jan C.
    Mueller, Matthias I.
    Alcazar, Miguel A. Alejandre
    Rietschel, Ernst
    van Koningsbruggen-Rietschel, Silke
    JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (02) : 271 - 275
  • [32] Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR
    Rowe, Steven M.
    McColley, Susanna A.
    Rietschel, Ernst
    Li, Xiaolei
    Bell, Scott C.
    Konstan, Michael W.
    Marigowda, Gautham
    Waltz, David
    Boyle, Michael P.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (02) : 213 - 219
  • [33] Effects of Lumacaftor-Ivacaftor on Airway Microbiota-Mycobiota and Inflammation in Patients with Cystic Fibrosis Appear To Be Linked to Pseudomonas aeruginosa Chronic Colonization
    Enaud, Raphael
    Lussac-Sorton, Florian
    Charpentier, Elena
    Velo-Suarez, Lourdes
    Guiraud, Jennifer
    Bui, Stephanie
    Fayon, Michael
    Schaeverbeke, Thierry
    Nikolski, Macha
    Burgel, Pierre-Regis
    Hery-Arnaud, Genevieve
    Delhaes, Laurence
    MICROBIOLOGY SPECTRUM, 2023, 11 (02):
  • [34] Treatment of Cystic Fibrosis Patients Homozygous for F508del with Lumacaftor-Ivacaftor (Orkambi®) Restores Defective CFTR Channel Function in Circulating Mononuclear Cells
    Favia, Maria
    Gallo, Crescenzio
    Guerra, Lorenzo
    De Venuto, Domenica
    Diana, Anna
    Polizzi, Angela Maria
    Montemurro, Pasqualina
    Mariggio, Maria Addolorata
    Leonetti, Giuseppina
    Manca, Antonio
    Casavola, Valeria
    Conese, Massimo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (07)
  • [35] Cost-effectiveness analysis of lumacaftor and ivacaftor combination for the treatment of patients with cystic fibrosis in the United States
    Dolly Sharma
    Shan Xing
    Yu-Ting Hung
    Rachel N. Caskey
    Maria L. Dowell
    Daniel R. Touchette
    Orphanet Journal of Rare Diseases, 13
  • [36] Cost-effectiveness analysis of lumacaftor and ivacaftor combination for the treatment of patients with cystic fibrosis in the United States
    Sharma, Dolly
    Xing, Shan
    Hung, Yu-Ting
    Caskey, Rachel N.
    Dowell, Maria L.
    Touchette, Daniel R.
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [37] SUSTAINED ANTI-INFLAMMATORY EFFECTS OF LUMACAFTOR-IVACAFTOR IN SPUTUM AND PERIPHERAL BLOOD SAMPLES OF ADULT CYSTIC FIBROSIS PATIENTS- AN OBSERVATIONAL STUDY
    Arooj, P.
    Morrissy, D.
    Ronan, N.
    McCarthy, Y.
    Fleming, C.
    Eustace, J. A.
    Murphy, D. M.
    Plant, B. J.
    THORAX, 2022, 77 : A20 - A21
  • [38] A One-Year Retrospective Analysis of the Effect of Elexacaftor-Tezacaftor-Ivacaftor on Lung Function in Cystic Fibrosis Patients with Advanced Lung Disease
    Bermingham, B.
    Rueschhoff, A.
    Ratti, G.
    Nesmith, A.
    Flume, P. A.
    Solomon, G. M.
    Cohen, L.
    Garcia, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [39] Real-life experience with a generic formulation of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the Phe508del CFTR mutation
    Teper, Alejandro
    Lubovich, Silvina
    Rodriguez, Viviana
    Zaragoza, Silvina
    Rodriguez, Ezequiel
    Bournissen, Facundo Garcia
    PEDIATRIC PULMONOLOGY, 2023, 58 (12) : 3560 - 3565
  • [40] Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years
    Berges, Julian
    Graeber, Simon Y.
    Haemmerling, Susanne
    Yu, Yin
    Kruempelmann, Arne
    Stahl, Mirjam
    Hirtz, Stephanie
    Scheuermann, Heike
    Mall, Marcus A.
    Sommerburg, Olaf
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345